FDA Greenlights Cancer Drug From China Amid Shortage | China In Focus

by EditorR

Cancer drugs are in short supply, and this problem is now gripping American health care. To help, the Food and Drug Administration (FDA) is greenlighting a cancer drug from China. Some applaud the decision, while others warn that Beijing could use medicines as a weapon against the United States by withholding supplies or selling drugs that lack effective ingredients.

Topics in this episode:

  1. FDA Greenlights Cancer Drug from China Amid Shortage
  2. Sequoia Capital Separates Its U.S., China Business
  3. TikTok Stars’ SSN Stored in China: Report
  4. Sec. of State Blinken to Visit China Soon: Report
  5. China, Russia Launch Joint Air Patrol near Japan
  6. ‘Silent Barker’: U.S. Spy Satellites to Counter China, Russia
  7. German Pilots Pass NATO’s Tactics to China
  8. Russian Airspace Closure Slows Foreign Flights To, from China
  9. China’s Wheat Growers Face ‘Disaster’ Amid Heavy Rain
  10. Cybersecurity Expert on ‘Severe’ Attack on U.S. Navy by Chinese Hackers

You may also like